CliffBio
small molecule

TRAVATAN Z

TRAVOPROST

Loss of exclusivityOctober 2029latest FDA-listed patent expiry
CompanySandoz →See this company's full patent-cliff portfolio

Drug detail

Brand nameTRAVATAN Z
Active ingredientTRAVOPROST
Strength0.004%
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalSeptember 2006
Marketing statusRX

Listed patents

PatentExpiresType
8268299October 2029product
8323630September 2027product
8388941September 2027product

More from Sandoz

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

TRAVATAN Z patent cliff — loss of exclusivity October 2029 | CliffBio